ARPharM

Home News A New ARPharM Main Board Elected

Video Clips



A New ARPharM Main Board Elected

E-mail Print PDF
April 20, 2017, Sofia
A new Main Board of the Association of Research'based Pharmaceutical Manufacturers in Bulgaria was elected
On April 20, 2017, a new Board of Directors of the Association was elected at a regular reporting-election meeting of the General Assembly of the Association of Research-based Pharmaceutical Manufacturers in Bulgaria

For Chairperson was elected Dr. Hristo Trunchev - Manager of Novartis Pharma for Bulgaria;
Deputy Chairperson Mrs. Zoya Paunova, Manager of AstraZeneca for Bulgaria.

The other members of the MB are:
Dr. Krasimira Chimishanska - Amgen
Mr. Nikolaos Xidias - GSK
Dr. Krum Kasabov - Novo Nordisk
Dr. Methodia Chadikowski - Roche
Mr. Aurelien Breton - Servier

Bayer Bulgaria was elected as the Controller of the Association.
The new leadership of the Association of Research-based Pharmaceutical Manufacturers in Bulgaria will continue the efforts of the organisation to improve the access of Bulgarian patients to quality, modern and effective drug treatment and will cooperate with all state institutions and organisations that set the same goal.